Curcumol inhibits hepatocellular carcinoma proliferation through miRNA-124/STAT3 pathway: Network pharmacology and experimental validation
Objective: Hepatocellular carcinoma (HCC) is the most common type of liver cancer and is one of the most common global cancers. Curcuma zedoaria (Christm.) Roscoe is a traditional Chinese herb that has been used for thousands of years in China to treat various types of cancer. Curcumol is one of its...
Saved in:
| Main Authors: | Gui-yu Li, Ji-yong Lin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Current Research in Biotechnology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590262824000960 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reversal of sorafenib resistance in hepatocellular carcinoma by curcumol: insights from network pharmacology, molecular docking, and experimental validation
by: Ni Zhang, et al.
Published: (2025-04-01) -
Multi-omics analysis of the anti-cancer effects of curcumol in endometrial carcinoma
by: Jumin Xie, et al.
Published: (2025-07-01) -
In Silico Prioritization of STAT1 3′ UTR SNPs Identifies rs190542524 as a miRNA-Linked Variant with Potential Oncogenic Impact
by: Ebtihal Kamal
Published: (2025-04-01) -
Recent progress in miRNA biogenesis and decay
by: Xavier Bofill-De Ros, et al.
Published: (2024-12-01) -
RETRACTED: Mir-124 Attenuates STAT3-Mediated TH17 Differentiation in Colitis-Driven Colon Cancer
by: Shiyong Lin, et al.
Published: (2020-12-01)